Published in Food and Drug Law Weekly, March 11th, 2005
The Gateway will centralize the receipt of submissions from regulated industry and other government agencies into a single system.
For the FDA e-submissions gateway solution, GNSI will use Cyclone Commerce's most advanced B2B platform, Cyclone Interchange, a transaction visibility solution, Cyclone Director, and Cyclone's extensive domain expertise. According to the company, Cyclone's solutions provide a secure, scalable network that serves as the foundation for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.